These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19430548

  • 1. Effect of beta2-adrenergic receptor polymorphism in asthma control of patients receiving combination treatment.
    Kim SH, Ye YM, Hur GY, Lee HY, Jee YK, Lee SH, Holloway JW, Park HS.
    Yonsei Med J; 2009 Apr 30; 50(2):182-8. PubMed ID: 19430548
    [Abstract] [Full Text] [Related]

  • 2. Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.
    Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M.
    Lancet; 2007 Dec 22; 370(9605):2118-25. PubMed ID: 18156033
    [Abstract] [Full Text] [Related]

  • 3. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.
    J Allergy Clin Immunol; 2006 Oct 22; 118(4):809-16. PubMed ID: 17030231
    [Abstract] [Full Text] [Related]

  • 4. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May 22; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 5. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, National Heart, Lung and Blood Institute's Asthma Clinical Research Network.
    Lancet; 2009 Nov 21; 374(9703):1754-64. PubMed ID: 19932356
    [Abstract] [Full Text] [Related]

  • 6. Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response.
    Ambrose HJ, Lawrance RM, Cresswell CJ, Goldman M, Meyers DA, Bleecker ER.
    Respir Res; 2012 May 04; 13(1):37. PubMed ID: 22559839
    [Abstract] [Full Text] [Related]

  • 7. Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy.
    Kim SH, Ye YM, Lee HY, Sin HJ, Park HS.
    J Clin Pharm Ther; 2011 Jun 04; 36(3):399-405. PubMed ID: 21545619
    [Abstract] [Full Text] [Related]

  • 8. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM, Greenstone IR, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Apr 18; (2):CD005307. PubMed ID: 15846751
    [Abstract] [Full Text] [Related]

  • 9. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.
    Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.
    Lancet; 2005 Apr 18; 364(9444):1505-12. PubMed ID: 15500895
    [Abstract] [Full Text] [Related]

  • 10. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ, Hall IP, Aziz I, Tan KS, Wheatley A.
    Clin Sci (Lond); 1999 Mar 18; 96(3):253-9. PubMed ID: 10029561
    [Abstract] [Full Text] [Related]

  • 11. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov 18; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 12. Impact of the Arg 16 allele of the B2AR gene on the effect of withdrawal of LABA in patients with moderate to severe asthma.
    Slankard M, Michelis MA, Mansukhani M, McGoey B, Paige A, Andrews H, Lederer D, Canfield S, DiMango E.
    J Asthma; 2016 Oct 18; 53(8):783-9. PubMed ID: 27050801
    [Abstract] [Full Text] [Related]

  • 13. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005533. PubMed ID: 16235409
    [Abstract] [Full Text] [Related]

  • 14. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
    Hancox RJ, Cowan JO, Flannery EM, Herbison GP, McLachlan CR, Wong CS, Taylor DR.
    Thorax; 1999 Jun 19; 54(6):482-7. PubMed ID: 10335000
    [Abstract] [Full Text] [Related]

  • 15. Pharmacogenetic study of the effects of NK2R G231E G>A and TBX21 H33Q C>G polymorphisms on asthma control with inhaled corticosteroid treatment.
    Ye YM, Lee HY, Kim SH, Jee YK, Lee SK, Lee SH, Park HS.
    J Clin Pharm Ther; 2009 Dec 19; 34(6):693-701. PubMed ID: 20175803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
    Ram FS, Cates CJ, Ducharme FM.
    Cochrane Database Syst Rev; 2005 Jan 25; (1):CD003137. PubMed ID: 15674901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.